1. |
Define the goal of critical incident monitoring. |
2. |
Define a “near miss.” |
3. |
Compare incident reporting systems with chart reviews and risk management in relation to preventable events. |
4. |
Describe the purpose of a root cause analysis according to the JCAHO mandate of 1997. |
5. |
Describe the template in the form of a tree or ”Ishikawa.” |
6. |
List the limitations of root cause analysis. |
7. |
Describe the functions of CDSSs. |
8. |
State the incident rates of ADEs per 100 admissions. |
9. |
Define a non- preventable ADE (adverse drug event). |
10. |
Define corollary. |
11. |
State the drug classification most commonly associated with preventable ADEs. |
12. |
State which group of hospitalized patients benefit most from clinical pharmacists in reducing ADEs. |
13. |
Describe a computerized ADE monitor. |
14. |
List the economic consequences of injuries due to drugs. |
15. |
List several “high risk” medications. |
16. |
State the primary intention of a heparin nomogram. |
17. |
List 2 reasons unit-dose dispensing of medications was developed. |
18. |
Describe the shift of unit-dosing from the nursing ward to the pharmacy. |
19. |
Describe the McLaughlin dispensing system. |
20. |
State a common complaint by nurses about a Pyxis Medstation. |
21. |
Define hand disinfection. |
22. |
State what percent of hospitalized patients contract a nosocomial infection. |
23. |
List one of the main reasons for poor handwashing compliance. |
24. |
State the length of time in seconds that is recommended for adequate hand hygiene. |
25. |
State the estimated cost per episode of each nosocomial infection. |
26. |
List several statistics regarding cost and acquisition rate for hospitalized patients. |
27. |
Describe the psychological effect of contact precaution on the isolated patient. |
28. |
State the estimated cost associated with c. difficile in the hospitalized patient. |
29. |
State the most common nosocomial infections. |
30. |
State the percent of urinary tract infection that make up nosocomial infections. |
31. |
Describe the use of silver in urethral catheters. |
32. |
List the two antibiotics used for antimicrobial impregnated catheters. |
33. |
Define catheter colonization. |
34. |
List the three common organisms causing catheter-related infections. |
35. |
List the maximum sterile barrier precautions. |
36. |
State the most common skin prep agent used prior to insertion of a central venous catheter. |
37. |
Define ventilator-associated pneumonia. |
38. |
Define continuous oscillation and how it is tolerated by conscious patients. |
39. |
State the goal of selective digestive tract decontamination. |
40. |
List several potential pitfalls of localizing care to high-volume settings. |
41. |
Describe the two general categories of complications from minimal access procedures. |
42. |
State the percent of injuries predicted to occur during a surgeon’s first 30 cases. |
43. |
Define a surgical site infection. |
44. |
Define antimicrobial prophylaxis and its purpose. |
45. |
List the consequences of intraoperative hypothermia. |
46. |
List complications of central venous catheterization after placement. |
47. |
State the greatest benefit of ultrasound guidance. |
48. |
State the number of sponge, sharp, and instrument counts recommended and describe each. |
49. |
State the surgery where most retained sponges are found. |
50. |
Describe the “checkout list” as stated in 1987 by the FDA. |
51. |
State why a generalized checklist would be difficult or impossible. |
52. |
List examples of invasive monitors. |
53. |
Define capnography. |
54. |
State the most common medical complication of surgery. |
55. |
List the benefits of beta-blockade for elderly patients. |
56. |
List the strongest predictor of future falls. |
57. |
List the problems of wearing an external hip protector. |
58. |
List two tools that are widely used to identify at-risk patients. |
59. |
State the measures required with the Omnibus Budget Reconciliation Act of 1987. |
60. |
State the cost of treating a pressure ulcer. |
61. |
Define delirium. |
62. |
List general strategies to prevent delirium. |
63. |
List the members of a consultation team provided by published studies and common features. |
64. |
List the functions of a multidisciplinary team in a GEM unit. |
65. |
Describe a GEM unit. |
66. |
Define “clinically silent.” |
67. |
State the “gold standard” for diagnosis of DVT. |
68. |
List the reasons DVT prophylaxis is under used. |
69. |
List the major risk factors for radiocontrast-induced nephropathy. |
70. |
State the percent of hospitalized patients who are malnourished. |
71. |
State a complication associated with TPN. |
72. |
List the three risks of stress ulceration and GI bleeding. |
73. |
Describe teleradiology. |
74. |
Describe the high-risk patient. |
75. |
State the most effective delivery method for inpatient settings. |
76. |
State the function of acute pain services post-operatively. |
77. |
List the most common side effects of patient-controlled analgesia with opioids. |
78. |
Describe a closed ICU model. |
79. |
State what part of a nurse’s job is the largest. |
80. |
Describe how increasing the percentage of RNs in the skill mix has decreased risk-adjusted mortality. |
81. |
Define the term High Reliability Organization. |
82. |
Describe the safety climate. |
83. |
Define ergonomics. |
84. |
Describe the experiment of recognizing six alarms at one time. |
85. |
Define sign-out. |
86. |
State the two most common reasons reported by physicians for not notifying patients of abnormal results. |
87. |
State the oldest and most common machine-readable ID system. |
88. |
List several common factors in wrong-site surgery. |
89. |
List the three primary components of effective crew management. |
90. |
Describe the MedTeams behavior-based teamwork system. |
91. |
List four advantages of simulation. |
92. |
State two potential risks to simulation-based training. |
93. |
Define “sleep debt.” |
94. |
Describe how shift rotation impacts worker fatigue. |
95. |
Define “sleep inertia.” |
96. |
Describe intrahospital and interhospital transports. |
97. |
State the mortality rate during interhospital and intrahospital transport. |
98. |
Define informed consent. |
99. |
State the grade level at which hospital forms are written, according to Hopper et al. |
100. |
Define advance directive, living will, and durable power of attorney for health care. |
101. |
State why advance directives often do not change end-of-life interventions. |
102. |
Describe the five-page “Patient Fact Sheet.” |
103. |
Define “practice guidelines.” |
104. |
Define Critical Pathways. |
105. |
Define a “clinical decision support system.” |
106. |
List three techniques used to modify behavior of physicians. |
107. |
List the purpose of survey results used by JCAHO. |